about
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administ...
Read More
1.11
0.03
(2.78%)
22,034.8
XNAS Volume
XNAS 25 Jun, 2026 4:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Immuron Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..